FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Workshop on Human Skin Safety Testing for Topicals

Federal Register notice: FDA announces a 9/10 public workshop entitled Human Dermal (Skin) Safety Testing for Topical Drug Products: Regulatory Utilit...

Human Drugs

FDA Approves Alnylams Onpattro for Nerve Disease

FDA approves an Alnylam Pharmaceuticals NDA for Onpattro (patisiran) infusion for treating peripheral nerve disease caused by hereditary transthyretin...

Federal Register

FDA Proposes New Drug Promotion Study on Disclosures

Federal Register notice: FDA submits to OMB a new information collection study entitled Disclosures in Professional and Consumer Prescription Drug Pro...

Human Drugs

Long-term Contraceptive Ring Approved

FDA approves a Population Council NDA for Annovera, first vaginal ring contraceptive that can be used for an entire year.

Medical Devices

Spacelabs Healthcare Recalls Anesthesia Device

Spacelabs Healthcare recalls the Arkon Anesthesia Delivery System due to the device going into a failed state, which causes the mechanical ventilation...

Medical Devices

Vyaire Medical Recalls AirLife Resuscitation Device

Vyaire Medical recalls its AirLife Resuscitation Device due to a manufacturing error.

Human Drugs

FDAers Find Increases in Tropical Disease Drug Development

Writing in PLOS online journal, three FDA researchers find a significant increase in the development of new tropical disease drugs after Congress enac...

Human Drugs

Drug Complex Innovative Designs Pilot Program

FDA outlines its planned Complex Innovative Designs Pilot Meeting Program that is intended to advance the use of complex adaptive, Bayesian, and other...

Federal Register

Guide on Drug Dissolution Testing

Federal Register notice: FDA makes available a guidance entitled Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage F...

Federal Register

Prolixin Not Withdrawn Due to Safety/Efficacy: FDA

Federal Register notice: FDA determines that Prolixin (fluphenazine hydrochloride) tablets, 1 mg (mg), 2.5 mg, 5 mg, and 10 mg, were not withdrawn fro...